Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleDrug Discovery and Translational Medicine

Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis

Gretchen Bain, Kristen E. Shannon, Fei Huang, Janice Darlington, Lance Goulet, Patricia Prodanovich, Gina L. Ma, Angelina M. Santini, Adam J. Stein, Dave Lonergan, Christopher D. King, Imelda Calderon, Andiliy Lai, John H. Hutchinson and Jilly F. Evans
Journal of Pharmacology and Experimental Therapeutics January 2017, 360 (1) 1-13; DOI: https://doi.org/10.1124/jpet.116.237156
Gretchen Bain
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kristen E. Shannon
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Huang
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice Darlington
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lance Goulet
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Prodanovich
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gina L. Ma
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angelina M. Santini
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam J. Stein
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dave Lonergan
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher D. King
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Imelda Calderon
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andiliy Lai
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John H. Hutchinson
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jilly F. Evans
PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 360 no. 1 1-13
DOI 
https://doi.org/10.1124/jpet.116.237156
PubMed 
27754931

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received August 9, 2016
  • Accepted October 14, 2016
  • Published online December 5, 2016.

Article Versions

  • Earlier version (October 17, 2016 - 12:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2016 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Gretchen Bain,
  2. Kristen E. Shannon,
  3. Fei Huang,
  4. Janice Darlington,
  5. Lance Goulet,
  6. Patricia Prodanovich,
  7. Gina L. Ma,
  8. Angelina M. Santini,
  9. Adam J. Stein,
  10. Dave Lonergan,
  11. Christopher D. King,
  12. Imelda Calderon,
  13. Andiliy Lai,
  14. John H. Hutchinson, and
  15. Jilly F. Evans
  1. PharmAkea Inc, San Diego, California (G.B., K.E.S., F.H., J.D., L.G., P.P., G.L.M., A.M.S., D.L., C.D.K., I.C., A.L., J.H.H., J.E.F.); Cayman Chemical Company, Ann Arbor, Michigan (A.J.S.)
  1. Address correspondence to:
    Dr. Gretchen Bain, 3030 Bunker Hill Street, Suite 300, San Diego, CA 92109. E-mail: gbain{at}pharmakea.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2016 to May 2023

AbstractFullPdf
Oct 20162750211
Nov 20161760189
Dec 2016498110145
Jan 201727266132
Feb 201721263122
Mar 20171484085
Apr 20172164977
May 20171583863
Jun 20171703863
Jul 20171303548
Aug 20172593783
Sep 20172065467
Oct 20171883664
Nov 20171765665
Dec 20172411674
Jan 20181510678
Feb 20181810086
Mar 20181210068
Apr 2018159783
May 20185128100
Jun 2018228799
Jul 2018695103
Aug 201858359
Sep 201818578
Oct 2018620060
Nov 20183177101
Dec 2018018264
Jan 2019111784
Feb 2019710192
Mar 2019178776
Apr 20192155120
May 2019514390
Jun 201997070
Jul 20198137128
Aug 2019110276
Sep 201967376
Oct 20191010182
Nov 20191416979
Dec 201918858
Jan 202047880
Feb 2020410489
Mar 202075855
Apr 202023863
May 202033958
Jun 202035164
Jul 202034158
Aug 202023243
Sep 202026462
Oct 202005752
Nov 202036948
Dec 202056555
Jan 202183544
Feb 202144552
Mar 2021104349
Apr 2021115339
May 202187534
Jun 202123332
Jul 202196242
Aug 202195051
Sep 202192436
Oct 202166057
Nov 202113065
Dec 202173446
Jan 2022103670
Feb 202282738
Mar 202272945
Apr 202273051
May 202272859
Jun 2022122744
Jul 2022123323
Aug 202254836
Sep 202242533
Oct 202282523
Nov 202242430
Dec 2022531427
Jan 202353912
Feb 202348311
Mar 20234798
Apr 202340417
May 202337913

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 360 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 360, Issue 1
1 Jan 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Selective Inhibition of Autotaxin Is Efficacious in Mouse Models of Liver Fibrosis
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleDrug Discovery and Translational Medicine

Autotaxin Inhibition Attenuates Mouse Liver Fibrosis

Gretchen Bain, Kristen E. Shannon, Fei Huang, Janice Darlington, Lance Goulet, Patricia Prodanovich, Gina L. Ma, Angelina M. Santini, Adam J. Stein, Dave Lonergan, Christopher D. King, Imelda Calderon, Andiliy Lai, John H. Hutchinson and Jilly F. Evans
Journal of Pharmacology and Experimental Therapeutics January 1, 2017, 360 (1) 1-13; DOI: https://doi.org/10.1124/jpet.116.237156

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleDrug Discovery and Translational Medicine

Autotaxin Inhibition Attenuates Mouse Liver Fibrosis

Gretchen Bain, Kristen E. Shannon, Fei Huang, Janice Darlington, Lance Goulet, Patricia Prodanovich, Gina L. Ma, Angelina M. Santini, Adam J. Stein, Dave Lonergan, Christopher D. King, Imelda Calderon, Andiliy Lai, John H. Hutchinson and Jilly F. Evans
Journal of Pharmacology and Experimental Therapeutics January 1, 2017, 360 (1) 1-13; DOI: https://doi.org/10.1124/jpet.116.237156
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PK/PD Relationship of RyR2 Inhibitor ent-Verticilide
  • TAK-994: An Orally Available Orexin 2 Receptor Agonist
  • Siponimod as a novel inhibitor of retinal angiogenesis
Show more Drug Discovery and Translational Medicine

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics